BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12945723)

  • 1. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.
    Vasoo S; Thumboo J; Fong KY
    Lupus; 2003; 12(8):630-2. PubMed ID: 12945723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Chang HK
    J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
    Samad AS; Lindsley CB
    South Med J; 2003 Jul; 96(7):705-7. PubMed ID: 12940327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    Tselios K; Gladman DD; Su J; Urowitz MB
    J Rheumatol; 2016 Mar; 43(3):552-8. PubMed ID: 26773121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
    Wen Y; Lu P; Lu H; Hu X
    Medicine (Baltimore); 2021 Jan; 100(2):e24231. PubMed ID: 33466204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
    J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C; Vollenhoven Rv
    Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
    Maroun MC; Ososki R; Andersen JC; Dhar JP
    Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of refractory thrombocytopenia in systemic lupus erythematosus that responded to intravenous low-dose cyclophosphamide.
    Park HJ; Kang MI; Kang Y; Chung SJ; Lee SW; Park YB; Lee SK
    J Korean Med Sci; 2013 Mar; 28(3):472-5. PubMed ID: 23487584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which dose of steroids and which cytotoxics for severe lupus?
    Lutalo PM; Jordan N; D'Cruz DP
    Presse Med; 2014 Jun; 43(6 Pt 2):e157-65. PubMed ID: 24882275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.